1. Home
  2. News
  3. Aurisco Pharmaceutical Co. Ltd.
  4. Announcement on Result of Shareholding Reduction by Shareholder
More Aurisco Pharmaceutical Co. Ltd. news
Aurisco Pharmaceutical Co. Ltd.SSE: 605116

Announcement on Result of Shareholding Reduction by Shareholder

Dec 25, 2025 · Issued by Aurisco Pharmaceutical Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Dec 25, 2025 · 3 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-result-of-shareholding-reduction-by-shareholder-81

Aurisco Pharmaceutical Co. Ltd. on 6ix

Earlier from Aurisco Pharmaceutical

  • Announcement on Passing GMP Compliance Inspection for DrugsDec 19, 2025
  • Announcement on Result of Shareholding Reduction by Senior Management MembersNov 27, 2025
  • Announcement on Obtaining Drug Registration Approval by the Wholly-owned SubsidiaryNov 26, 2025
  • Announcement on Convening the Q3 2025 Performance BriefingNov 15, 2025
  • Announcement on Shareholding Reduction Plan for ShareholdersNov 5, 2025

Later from Aurisco Pharmaceutical

  • Announcement on the Implementation of Repurchase and Cancellation of Partial Restricted StocksDec 31, 2025
  • Announcement on Progress in Repurchasing Shares through Call AuctionJan 5
  • Announcement on Adjusting Upper Limit of Repurchase PriceJan 13
  • Announcement on Implementation Result of Shares Repurchase and Share ChangesJan 22
  • Announcement on Shareholding Reduction Plan for Partial Board of DirectorsJan 31
All Aurisco Pharmaceutical news releases↗

Follow Aurisco Pharmaceutical into a list and get an email when it puts out news.

Follow Aurisco Pharmaceutical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer